Pancreatic Cancer Research

ResearcherComprehensive Cancer Center ViennaActive in the last 2 years

Hossein Taghizadeh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0927-6498; OpenAlex author ID A5014395094. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. NALIRIFOX in the treatment of metastatic pancreatic ductal adenocarcinoma: an exploratory analysis of real-world data. Co-author DOI 10.1016/j.esmoop.2025.105827↗
  2. Applied precision medicine in metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1177/1758835920938611↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gerald W. Prager · 2 shared papers, 2020–2025 · strength 0.36
  2. Andreas Reichinger · 1 shared paper, 2025 · strength 0.22
  3. Holger F. Rumpold · 1 shared paper, 2025 · strength 0.22
  4. Patrick Kirchweger · 1 shared paper, 2025 · strength 0.22
  5. Bernhard Doleschal · 1 shared paper, 2025 · strength 0.22
  6. Martin Schindl · 1 shared paper, 2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.